Nedaplatin

Chemical compound
  • none
Legal statusLegal status
  • In general: ℞ (Prescription only)
Identifiers
  • Diammine[(hydroxy-κO)acetato(2-)-κO]platinum
CAS Number
  • 95734-82-0 checkY
PubChem CID
  • 9796440
ChemSpider
  • 7972206
UNII
  • 8UQ3W6JXAN
KEGG
  • D01416 checkY
CompTox Dashboard (EPA)
  • DTXSID8046878 Edit this at Wikidata
Chemical and physical dataFormulaC2H8N2O3PtMolar mass303.181 g·mol−13D model (JSmol)
  • Interactive image
  • coordination form: Interactive image
  • C(C(=O)[O-])[O-].N.N.[Pt+2]

  • coordination form: O=C1O[Pt-2]([NH3+])([NH3+])OC1
InChI
  • InChI=1S/C2H3O3.2H3N.Pt/c3-1-2(4)5;;;/h1H2,(H,4,5);2*1H3;/q-1;;;+2/p-1
  • Key:GYAVMUDJCHAASE-UHFFFAOYSA-M
  (verify)

Nedaplatin (INN, marketed under the tradename Aqupla) is a platinum-based antineoplastic drug which is used for cancer chemotherapy.[1] The complex consists of two ammine ligands and the dianion derived from glycolic acid.

Platinum-based drugs are widely employed as antineoplastic agents, especially cisplatin and carboplatin. Due to issues of their toxicity and number of cisplatin-resistant cancer cells, other platinum derivatives have been developed. Nedaplatin is one example of such new drugs.[2]

References

  1. ^ Apps MG, Choi EH, Wheate NJ (August 2015). "The state-of-play and future of platinum drugs". Endocrine-Related Cancer. 22 (4): R219-33. doi:10.1530/ERC-15-0237. hdl:2123/24426. PMID 26113607.
  2. ^ Johnstone TC, Park GY, Lippard SJ (January 2014). "Understanding and improving platinum anticancer drugs--phenanthriplatin". Anticancer Research. 34 (1): 471–6. PMC 3937549. PMID 24403503.

External links

  • "Aqupla アクプラ" (PDF). Shionogi & Co. March 2007. Archived from the original (PDF) on 2004-08-05.
  • "Official Shionogi & Co. Website" (in Japanese).
  • v
  • t
  • e
SPs/MIs
(M phase)
Block microtubule assembly
Block microtubule disassembly
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Purine
Pyrimidine
Deoxyribonucleotide
Topoisomerase inhibitors
(S phase)
I
II
II+Intercalation
Crosslinking of DNA
(CCNS)
Alkylating
Platinum-based
Nonclassical
Intercalation
Photosensitizers/PDTOther
Enzyme inhibitors
Receptor antagonists
Other/ungrouped
  • v
  • t
  • e
Pt(-II)
  • Cs2Pt
Pt(0)
  • Pt(PPh3)4
Pt(II)
  • Pt(NH3)2(CO2)2C4H6
  • cis-Pt(NH3)2Cl2
  • trans-Pt(NH3)2Cl2
  • K2Pt(CN)4
  • Pt(NH3)4PtCl4
  • Pt(NH3)2CO2CH2O
  • (Cy(NH2)2)PtC2O4
  • NH3PtCl2(PyrMe)
  • Pt(OAc)2
  • PtBr2
  • PtCl2
  • PtF2
  • PtI
    2
  • PtP2
  • K2PtCl4
  • [(PtCl(NH3)2(C6H12(NH2)2))Pt(NH3)2](NO3)4
  • Pt(OH)2
  • PtSm
  • Pt(C5H7O2)2
  • PtS
Organoplatinum(II) compounds
  • PtCl2(Cod)
  • Pt(CNO)2
  • KPtCl3C2H4
  • Pt(IV)
    • PtO2
    • (NH4)2PtCl6
    • H2PtCl6
    • PtBr4
    • PtCl4
    • PtF4
    • K2PtCl6
    • Pt(OAc)2Cl2(NH3)(NH2Cy)
    • Na2PtCl6
    • Pt(OH)4
    • PtI4
    • PtS2
    • PtSe2
    Pt(V)
    • PtF5
    • O2PtF6
    • XePtF6
    Pt(VI)
    • PtF6
    Stub icon

    This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

    • v
    • t
    • e